- Home
- BMY vs BX Comparison
BMY vs BX Comparison
Compare BMY & BX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- BX
- Stock Information
- Founded
- BMY 1887
- BX 1985
- Country
- BMY United States
- BX United States
- Employees
- BMY N/A
- BX N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- BX Investment Managers
- Sector
- BMY Health Care
- BX Finance
- Exchange
- BMY Nasdaq
- BX Nasdaq
- Market Cap
- BMY 97.6B
- BX 105.4B
- IPO Year
- BMY N/A
- BX 2007
- Fundamental
- Price
- BMY $47.38
- BX $168.76
- Analyst Decision
- BMY Hold
- BX Buy
- Analyst Count
- BMY 16
- BX 17
- Target Price
- BMY $58.00
- BX $162.06
- AVG Volume (30 Days)
- BMY 14.5M
- BX 4.1M
- Earning Date
- BMY 07-31-2025
- BX 07-24-2025
- Dividend Yield
- BMY 5.24%
- BX 2.34%
- EPS Growth
- BMY N/A
- BX 16.59
- EPS
- BMY 2.67
- BX 3.31
- Revenue
- BMY $47,636,000,000.00
- BX $12,372,735,000.00
- Revenue This Year
- BMY N/A
- BX N/A
- Revenue Next Year
- BMY N/A
- BX $28.78
- P/E Ratio
- BMY $17.74
- BX $51.10
- Revenue Growth
- BMY 4.62
- BX 24.64
- 52 Week Low
- BMY $41.61
- BX $115.66
- 52 Week High
- BMY $63.33
- BX $200.96
- Technical
- Relative Strength Index (RSI)
- BMY 49.27
- BX 68.72
- Support Level
- BMY $46.18
- BX $159.18
- Resistance Level
- BMY $48.36
- BX $163.60
- Average True Range (ATR)
- BMY 1.08
- BX 3.99
- MACD
- BMY 0.10
- BX 1.35
- Stochastic Oscillator
- BMY 49.39
- BX 80.06
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About BX Blackstone Inc.
Blackstone is the world's largest alternative-asset manager with $1.167 trillion in total asset under management, including $860.1 billion in fee-earning assets under management, at the end of March 2025. The company has four core business segments: private equity (26% of fee-earning AUM and 30% of base management fees), real estate (34% and 40%), credit and insurance (32% and 23%), and multi-asset investing (8% and 7%). While the firm primarily serves institutional investors (87% of AUM), it also caters to clients in the high-net-worth channel (13%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).